DK1200832T3 - Annexiner og autoantistoffer anvendt som markörer for lungecancer og ösofageal cancer - Google Patents

Annexiner og autoantistoffer anvendt som markörer for lungecancer og ösofageal cancer

Info

Publication number
DK1200832T3
DK1200832T3 DK00952594T DK00952594T DK1200832T3 DK 1200832 T3 DK1200832 T3 DK 1200832T3 DK 00952594 T DK00952594 T DK 00952594T DK 00952594 T DK00952594 T DK 00952594T DK 1200832 T3 DK1200832 T3 DK 1200832T3
Authority
DK
Denmark
Prior art keywords
cancer
annexins
markers
oesophageal
lung cancer
Prior art date
Application number
DK00952594T
Other languages
Danish (da)
English (en)
Inventor
Samir M Hanash
David Misek
Robert Hinderer
David Beer
Franck Brichory
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Application granted granted Critical
Publication of DK1200832T3 publication Critical patent/DK1200832T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4718—Lipocortins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK00952594T 1999-08-06 2000-08-04 Annexiner og autoantistoffer anvendt som markörer for lungecancer og ösofageal cancer DK1200832T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/370,337 US6645465B2 (en) 1999-08-06 1999-08-06 Annexin proteins and autoantibodies as serum markers for cancer

Publications (1)

Publication Number Publication Date
DK1200832T3 true DK1200832T3 (da) 2006-09-18

Family

ID=23459219

Family Applications (2)

Application Number Title Priority Date Filing Date
DK00952594T DK1200832T3 (da) 1999-08-06 2000-08-04 Annexiner og autoantistoffer anvendt som markörer for lungecancer og ösofageal cancer
DK06075982T DK1734368T3 (da) 1999-08-06 2000-08-04 Annexin-autoantistoffer anvendt som markörer for lungecancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK06075982T DK1734368T3 (da) 1999-08-06 2000-08-04 Annexin-autoantistoffer anvendt som markörer for lungecancer

Country Status (10)

Country Link
US (5) US6645465B2 (fr)
EP (3) EP2051079B1 (fr)
JP (1) JP4594575B2 (fr)
AT (3) ATE529751T1 (fr)
AU (1) AU780772B2 (fr)
CA (1) CA2380398C (fr)
DE (2) DE60041839D1 (fr)
DK (2) DK1200832T3 (fr)
ES (2) ES2320585T3 (fr)
WO (1) WO2001011372A1 (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810040D0 (en) 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB9827228D0 (en) * 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
US6645465B2 (en) * 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer
US20030232399A1 (en) * 2000-06-14 2003-12-18 Robertson John Forsyth Russell Cancer detection methods and reagents
CN1250567C (zh) * 2000-07-21 2006-04-12 财团法人化学及血清疗法研究所 钙离子结合蛋白的提纯方法
US7635676B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
US7645739B2 (en) 2001-02-21 2010-01-12 Alavita Pharmaceuticals, Inc. Modified annexin compositions and methods of using same
US7635680B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaceuticals, Inc. Attenuation of reperfusion injury
AU2002252035A1 (en) 2001-02-21 2002-09-12 Surromed, Inc. Modified annexin proteins and methods for preventing thrombosis
US7214498B2 (en) * 2001-03-23 2007-05-08 Benaroya Research Institute At Virginia Mason Tumor associated antigens and methods of using the same
EP1428028A2 (fr) * 2001-09-14 2004-06-16 Reinhard Zeidler Identification d'antigenes par precipitation provoquee au moyen d'anticorps xenogenes, allogenes ou autologues
EP1451587A4 (fr) * 2001-11-09 2006-12-06 Benaroya Res Inst At Virginia Panneaux d'antigenes et procedes d'utilisation associes
GB2395270B (en) * 2002-11-14 2006-08-16 Univ Nottingham Tumour marker proteins and uses thereof
WO2004079368A2 (fr) 2003-03-08 2004-09-16 Auvation Ltd Marqueurs cancereux
CA2555866A1 (fr) * 2004-02-16 2005-08-25 Proteosys Ag Marqueur diagnostique pour le cancer
WO2005114192A1 (fr) * 2004-05-13 2005-12-01 Centre National De La Recherche Scientifique Dispositif liant une entite cible a une entite appat et procedes de detection l'utilisant
US20060024722A1 (en) * 2004-07-30 2006-02-02 Mark Fischer-Colbrie Samples for detection of oncofetal fibronectin and uses thereof
RU2277242C2 (ru) * 2004-08-23 2006-05-27 Александр Владимирович Балюра Способ диагностики опухолей
JP4521575B2 (ja) * 2005-03-17 2010-08-11 国立大学法人 千葉大学 特発性肺線維症の検出マーカー、検出キット及び検出方法
EP1724585A1 (fr) * 2005-05-21 2006-11-22 ProteoSys AG Annexin pour l'évaluation du risque de cancer
EP1724586A3 (fr) * 2005-05-21 2007-07-04 ProteoSys AG Annexine pour l'évaluation du risque de cancer
SI1889059T1 (sl) 2005-05-27 2009-12-31 Oncimmune Ltd Izboljšani imunotestni postopek
GB2426581A (en) * 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
US20060286074A1 (en) * 2005-05-31 2006-12-21 Yucheng Tang Methods for immunotherapy of cancer
US8999727B2 (en) * 2005-09-26 2015-04-07 Ulrich Loos Innovative TSH-R-Ab-kit
CA2632190A1 (fr) * 2005-11-10 2007-07-12 University Of Kentucky Dosage de diagnostic de cancer du poumon
US9347945B2 (en) * 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
CN101490550A (zh) * 2006-07-08 2009-07-22 肯塔基大学研究基金会 肺癌诊断分析
CN101632020B (zh) 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
EP2097750A2 (fr) * 2006-10-26 2009-09-09 Abbott Laboratories Analyse immunologique d'analytes dans des echantillons contenant des anticorps anti-analytes endogenes
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
US20090047689A1 (en) * 2007-06-20 2009-02-19 John Kolman Autoantigen biomarkers for early diagnosis of lung adenocarcinoma
GB0725239D0 (en) * 2007-12-24 2008-02-06 Oncimmune Ltd Calibrator for autoantibody assay
EP2277049A4 (fr) * 2008-05-09 2012-05-30 Univ Duke Auto-anticorps dans la détection et le traitement du cancer
US9581599B2 (en) 2010-06-28 2017-02-28 The Board Of Regents Of The University Of Texas System Diagnosis of benign and cancerous growths by measuring circulating tumor stem cells and serum AnnexinA2
US9555074B2 (en) 2010-10-08 2017-01-31 Regents Of The University Of Minnesota Annexin II compositions
KR20150010882A (ko) * 2013-07-19 2015-01-29 삼성전자주식회사 아넥신 Ａ2 결합단백질, ｐ53 단백질 및 ｐ18 단백질을 포함하는 융합 단백질 및 이를 포함하는 암의 예방 또는 치료용 조성물
WO2015039175A1 (fr) 2013-09-18 2015-03-26 Adelaide Research & Innovation Pty Ltd Biomarqueurs d'autoanticorps du cancer des ovaires
PL3068428T3 (pl) 2013-11-13 2023-03-13 Regents Of The University Of Minnesota Sposoby i kompozycje wariantów aneksyny ii
CN104407151B (zh) * 2014-11-19 2016-06-08 汕头大学医学院 Kindlin-2，Myosin-9和Annexin II三蛋白联合预测食管鳞癌患者预后试剂盒
CN113721021B (zh) * 2021-09-16 2023-07-07 郑州大学 Prkcz自身抗体在食管鳞癌辅助诊断中的应用
CN116539885B (zh) * 2023-07-06 2023-09-29 上海秤信生物科技有限公司 用于乳腺癌早期检测的肿瘤自身抗原/抗体组合及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02496A (ja) * 1987-12-24 1990-01-05 Nippon Shinyaku Co Ltd モノクローナル抗体、製法、及び利用法
DE4012341A1 (de) * 1990-04-18 1991-10-24 Behringwerke Ag Monoklonale antikoerper gegen pp4, verfahren zu ihrer herstellung und ihre verwendung
DE4040306A1 (de) 1990-12-17 1992-06-25 Behringwerke Ag Verfahren zur bestimmung von antikoerpern gegen lipocortine
US5405749A (en) * 1991-12-06 1995-04-11 Polans; Arthur S. Method for identifying and purifying a cancer associated retinopathy autoantigen, and testing patient serum for the autoantibody to the autoantigen
JPH0772149A (ja) * 1993-06-30 1995-03-17 Nippon Shinyaku Co Ltd 肝癌又は肝硬変の診断薬及び診断法
JPH0772147A (ja) * 1993-07-02 1995-03-17 Noboru Kaneko 抗アネキシンｖ抗体並びに該抗体の製法及び利用
EP0651253A1 (fr) * 1993-11-02 1995-05-03 Abbott Laboratories Essai immunologique pour la detéction des autoanticorps humaines
US5658877A (en) * 1995-05-18 1997-08-19 Wisconsin Alumni Research Foundation Method to treat endotoxin effects by administration of 33 kilodalton phospholipid binding protein
DE69823660D1 (de) 1997-06-26 2004-06-09 Univ Michigan Ann Arbor Methode zur identifizierung von tumorantigenen mit autoantikörpern in serum
WO1999018435A1 (fr) * 1997-10-08 1999-04-15 International Reagents Corporation Procede d'analyse de l'annexine v dans l'urine et utilisation
AU762512B2 (en) * 1998-12-28 2003-06-26 Atossa Genetics, Inc. Devices, methods and systems for collecting material from a breast duct
US6645465B2 (en) * 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer

Also Published As

Publication number Publication date
AU780772B2 (en) 2005-04-14
EP2051079A3 (fr) 2009-06-10
EP1734368A3 (fr) 2007-03-07
JP4594575B2 (ja) 2010-12-08
US20040048320A1 (en) 2004-03-11
CA2380398A1 (fr) 2001-02-15
DE60041839D1 (de) 2009-04-30
US20100330587A1 (en) 2010-12-30
WO2001011372A1 (fr) 2001-02-15
DE60028040T2 (de) 2006-11-23
ES2320585T3 (es) 2009-05-25
EP2051079A2 (fr) 2009-04-22
US20060275845A1 (en) 2006-12-07
EP1200832B1 (fr) 2006-05-17
EP1734368A2 (fr) 2006-12-20
ATE326699T1 (de) 2006-06-15
JP2003535309A (ja) 2003-11-25
EP1734368B1 (fr) 2009-03-18
ATE426167T1 (de) 2009-04-15
EP1200832A1 (fr) 2002-05-02
EP2051079B1 (fr) 2011-10-19
US20020168696A1 (en) 2002-11-14
US7759081B2 (en) 2010-07-20
DE60028040D1 (de) 2006-06-22
US6645465B2 (en) 2003-11-11
AU6526200A (en) 2001-03-05
WO2001011372A9 (fr) 2002-04-11
DK1734368T3 (da) 2009-06-02
ES2259609T3 (es) 2006-10-16
US20070037227A1 (en) 2007-02-15
CA2380398C (fr) 2017-01-31
US7955602B2 (en) 2011-06-07
ATE529751T1 (de) 2011-11-15

Similar Documents

Publication Publication Date Title
DK1734368T3 (da) Annexin-autoantistoffer anvendt som markörer for lungecancer
Hill et al. Preserved proteins from extinct Bison latifrons identified by tandem mass spectrometry; hydroxylysine glycosides are a common feature of ancient collagen
DE60129151D1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
DK2154248T3 (da) Forbindelser og fremgangsmåder til diagnose af tuberkulose
EP1333274A3 (fr) Rapporteurs à conversion vers le haut destinés à des dosages biologiques et autres effectués à l'aide de techniques d'excitation au laser
DE69723860D1 (de) VERFAHREN ZUR BESTIMMUNG VON IgE
DE69719057D1 (de) Verfahren zur signalverstärkung
ATE312946T1 (de) Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten
PT1137943E (pt) Metodo e reagentes para a deteccao de cancro
ATE424560T1 (de) Marker für neuromyelitis optica
WO2008063479A3 (fr) Biomarqueurs du cancer du pancréas
ATE320006T1 (de) Methode zum nachweis von zell-apoptose
DE60300339D1 (de) Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
ATE447713T1 (de) S100-proteine und -autoantikörper als serummarker für krebs
ATE422671T1 (de) Verfahren zur diagnose von morbus alzheimer
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
DK1664793T3 (da) Neurotoksisk aminosyre eller neurotoksisk derivat deraf forbundet med neurologiske lidelser
WO2007030949A3 (fr) Procedes de diagnostic de cancer des ovaires et necessaires a cet effet
WO2004109286A3 (fr) Procedes de detection et de traitement du cancer
WO2007020522A3 (fr) Marqueurs proteiniques permettant de diagnostiquer un cancer colorectal et utilisation de ces marqueurs comme cibles de medicament en vue du traitement de ce type de cancer
FR2786787B1 (fr) Methode d'analyse in vitro d'un phenotype connu a partir d'un echantillon d'acides nucleiques
DE602005023329D1 (de) VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8
DE60311278D1 (de) Immunochromatographiesystem und verfahren zur gleichzeitigen identifikation von aga-und t-tg-antikörpern und verwendung dafür zur diagnose der zöliakiekrankheit
DE59910326D1 (de) Verwendung derivatisierter Reagenzien in Chemilumineszenz- und Elektrochemilumineszenz-Nachweisverfahren